Showing 1621-1630 of 7117 results for "".
Dr. Simpson Highlights Potentially Remittive Anti-OX40s at Maui Derm
https://reachmd.com/programs/practical-dermatology/dr-simpson-highlights-potentially-remittive-anti-ox40s-at-maui-derm/32920/Two anti-OX40 drugs in the pipeline may have remittive properties for atopic dermatitis, according to Eric Simpson, MD.Recap of Maui Derm Hawaii Meeting
https://practicaldermatology.com/series/dermwire-tv/recap-of-maui-derm-hawaii-meeting/32717/In this week's DermwireTV, key stakeholders in dermatology gather in Hawaii to discuss the latest developments and advances; a new review examines whether IgE-targeting therapies could represent a new treatment avenue for psoriasis and atherosclerosis; and the founder of SEEN hair care joSDPA: Medical Director Dr. Hilary Baldwin Discusses Acne and Keloids Lectures
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-medical-director-dr-hilary-baldwin-discusses-acne-and-keloids-lectures/29508/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with conference medical director Hilary Baldwin, MD. She explains the key takeaways of her lectures on acne and keloids.Science of Skincare Summit 2024:What's Going On With Medical Dermatology?
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-whats-going-on-with-medical-dermatology/29451/Todd Schlesinger, MD, James Del Rosso, DO, and Neal Bhatia, MD, discuss challenges facing medical dermatology, and what can be done to save it, as well as the importance of encouraging young dermatologists to become involved with clinical research. This discussion was recorded at the Science of SkinScience of Skincare Summit 2024:Presentation of Disease in Patients with Skin of Color
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-presentation-of-disease-in-patients-with-skin-of-color/29456/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Nada Elbuluk, MD, a dermatologist at the University of Southern California specializing in pigmentary disorders and skin of color, about some of the challenges of diagnosing disease such as erythema in patients with skin of colorInnovative Techniques for Forehead Wrinkles, Acne Laser Treatment, and More
https://practicaldermatology.com/conferences/maui-derm-2024/innovative-techniques-for-forehead-wrinkles-acne-laser-treatment-and-more/20250/Valerie D. Callender, MD, discusses the 3 cases she presented at Maui Derm 2024: filling in deeply etched forehead wrinkles with a resilient hyaluronic acid filler, treating acne with the 1726 nanometer laser, and treating melasma with a triple-combo procedure that includes maintenance therapy.Factor in Patient Satisfaction Matrix for Best Results
https://practicaldermatology.com/conferences/maui-derm-2024/factor-in-patient-satisfaction-matrix-for-best-results/20249/Chief Medical Editor Neil Bhatia, MD speaks with Maui Derm presenter and educator William P. Werschler, MD about cosmetic updates, including his “patient satisfaction matrix” that helps doctors and patients align on expectations of the outcomes of procedures.Pigmentation: Melasma vs. Postinflammatory Hyperpigmentation
https://practicaldermatology.com/conferences/maui-derm-2024/pigmentation-melasma-vs-hyperpigmentation-vitiligo-treatments-and-full-spectrum-photo-protection/20247/Chief Medical Editor Neal Bhatia, MD and Pearl Grimes, MD, discuss Dr. Grimes’ presentations on pigmentation, including the difference between melasma and postinflammatory hyperpigmentation, and the importance of photo-protection in darker skin types.How New Molluscum Contagiosum Treatments Will Boost QoL and Limit Infection
https://practicaldermatology.com/topics/pediatric/how-new-molluscum-contagiosum-treatments-will-boost-qol-and-limit-infection/20244/Adam Friedman, MD, George Washington School of Medicine discusses the first FDA-approved nitric-oxide based drug in dermatology plus other recent approvals that he believes will make patients lives much easier and reduce the continuity of this condition.“No Drug is 100 Percent.”
https://practicaldermatology.com/conferences/maui-derm-2024/no-drug-is-100-percent/20242/Jason Hawkes, MD and Chief Medical Editor Neal Bhatia, MD discuss how the current array of options for patients of chronic spontaneous urticaria (CSU) expand treatment options for hives beyond antihistamines.